EUVIMEDEUVIMED entdecken
Systematische ÜbersichtÜbersichtsarbeit

Barriers and Strategies to Enhance CAR ‐T Cell Infiltration in Solid Tumours: A Systematic Review

Yan Zhang iD, Huihui Sun, Lianfeng Zhao iD, Ningning Zhao, Zhengliang Chen, Lingfeng He iD, Zhigang Guo, Jun Yu

Immunology · 2026-05 · 178 (1) · 62-78

DOI: 10.1111/imm.70094 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Immunology, online erschienen am 19.01.2026. Verfasst von Yan Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China. Hauptthemen laut MEDLINE: Neoplasms, Immunotherapy, Adoptive, Receptors, Chimeric Antigen, Lymphocytes, Tumor-Infiltrating. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 183 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Chimeric antigen receptor T (CAR‐T) cell therapy has revolutionised the treatment of hematologic malignancies, achieving durable and robust responses. However, the application of CAR‐T cells in solid tumours remains limited by a complex network of barriers, most notably poor tumour infiltration. The key obstacles include mismatch between chemokines and receptors, abnormal tumour vasculature, immunosuppressive cellular populations (such as myeloid‐derived suppressor cells, tumour‐associated macrophages and regulatory T cells), dense network of cancer‐associated fibroblasts and extracellular matrix, T cell dysfunction and exhaustion, metabolic limitations within the tumour microenvironment, tumour heterogeneity and transport limitations related to tumour location. By integrating mechanistic insights with innovative bioengineering and combination approaches, this review systematically elaborates on the factors that limit the infiltration of CAR‐T cells and emphasises transformation strategies for improving the efficacy, durability and invasiveness of treating solid tumours.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NeoplasmsImmunotherapy, AdoptiveReceptors, Chimeric AntigenLymphocytes, Tumor-InfiltratingT-LymphocytesHumansTumor MicroenvironmentAnimals

Stichwörter der Autor:innen

CAR‐T cell therapytumour infiltrationtumour microenvironment

Substanzen

Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Jiangsu Key Laboratory for Molecular and Medical Biotechnology, College of Life Sciences, Nanjing Normal University, Nanjing, China.
  • The Pancreas Center, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin's Clinical Research Center for Cancer, Tianjin Key Laboratory of Digestive Cancer, Tia…

ORCID-Profile: Yan Zhang, Lianfeng Zhao, Lingfeng He

Zitieren

APA

Zhang, Y., Sun, H., Zhao, L., Zhao, N., Chen, Z., He, L., Guo, Z., & Yu, J. (2026). Barriers and Strategies to Enhance CAR ‐T Cell Infiltration in Solid Tumours: A Systematic Review. Immunology, 178(1), 62-78. https://doi.org/10.1111/imm.70094

Vancouver

Zhang Y, Sun H, Zhao L, Zhao N, Chen Z, He L, et al. Barriers and Strategies to Enhance CAR ‐T Cell Infiltration in Solid Tumours: A Systematic Review. Immunology. 2026;178(1):62-78. doi:10.1111/imm.70094

BibTeX
@article{Zhang2026,
  author = {Zhang, Yan and Sun, Huihui and Zhao, Lianfeng and Zhao, Ningning and Chen, Zhengliang and He, Lingfeng and Guo, Zhigang and Yu, Jun},
  title = {Barriers and Strategies to Enhance CAR ‐T Cell Infiltration in Solid Tumours: A Systematic Review},
  journal = {Immunology},
  year = {2026},
  volume = {178},
  number = {1},
  pages = {62--78},
  doi = {10.1111/imm.70094}
}
Kostenlos starten →